These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18722865)

  • 1. MVP and vinorelbine for malignant pleural mesothelioma.
    Mordant P; Loriot Y; Soria JC; Deutsch E
    Lancet; 2008 Aug; 372(9639):629; author reply 629-30. PubMed ID: 18722865
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant mesothelioma--the UK experience.
    O'Brien ME
    Lung Cancer; 2004 Aug; 45 Suppl 1():S133-5. PubMed ID: 15261447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of vinorelbine in patients with malignant pleural mesothelioma.
    Steele JP; Shamash J; Evans MT; Gower NH; Tischkowitz MD; Rudd RM
    J Clin Oncol; 2000 Dec; 18(23):3912-7. PubMed ID: 11099320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.
    Fennell DA; Parmar A; Shamash J; Evans MT; Sheaff MT; Sylvester R; Dhaliwal K; Gower N; Steele J; Rudd R
    J Clin Oncol; 2005 Jan; 23(1):184-9. PubMed ID: 15625372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural Mesothelioma.
    Zimling ZG; Santoni-Rugiu E; Bech C; Sørensen JB
    Anticancer Res; 2015 Dec; 35(12):6731-8. PubMed ID: 26637889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine.
    Baas P
    Semin Oncol; 2002 Feb; 29(1):62-9. PubMed ID: 11836670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to chemotherapy of brain metastases from malignant pleural mesothelioma.
    Colleoni M; Liessi G; Avventi C; Pancheri F; Sgarbossa G; Vicario G; Manente P
    Tumori; 1996; 82(5):456-8. PubMed ID: 9063523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council.
    Girling DJ; Muers MF; Qian W; Lobban D
    Semin Oncol; 2002 Feb; 29(1):97-101. PubMed ID: 11836674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112.
    Muers MF; Rudd RM; O'Brien ME; Qian W; Hodson A; Parmar MK; Girling DJ;
    Thorax; 2004 Feb; 59(2):144-8. PubMed ID: 14760156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of malignant mesothelioma with methotrexate and vinblastine, with or without platinum chemotherapy.
    Hunt KJ; Longton G; Williams MA; Livingston RB
    Chest; 1996 May; 109(5):1239-42. PubMed ID: 8625674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma.
    Sørensen JB; Frank H; Palshof T
    Br J Cancer; 2008 Jul; 99(1):44-50. PubMed ID: 18542078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vinorelbine in patients with malignant pleural mesothelioma--a phase II study].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2001 Aug; 177(8):440-1. PubMed ID: 11544910
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy for malignant pleural mesothelioma.
    Vogelzang NJ
    Lancet; 2008 May; 371(9625):1640-2. PubMed ID: 18486725
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective chemotherapy based on a chemosensitivity test for malignant pleural mesothelioma.
    Maniwa Y; Yoshimura M; Takata M; Nishimura Y; Ohno Y
    Ann Thorac Cardiovasc Surg; 2008 Oct; 14(5):319-21. PubMed ID: 18989249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.
    Muers MF; Stephens RJ; Fisher P; Darlison L; Higgs CM; Lowry E; Nicholson AG; O'Brien M; Peake M; Rudd R; Snee M; Steele J; Girling DJ; Nankivell M; Pugh C; Parmar MK;
    Lancet; 2008 May; 371(9625):1685-94. PubMed ID: 18486741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
    Vokes EE
    Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma.
    Andreopoulou E; Ross PJ; O'Brien ME; Ford HE; Priest K; Eisen T; Norton A; Ashley S; Smith IE
    Ann Oncol; 2004 Sep; 15(9):1406-12. PubMed ID: 15319247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge].
    Shukuya T; Takahashi T; Nakamura Y; Yamamoto N
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):487-90. PubMed ID: 20332689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for malignant pleural mesothelioma: past results and recent developments.
    Tomek S; Manegold C
    Lung Cancer; 2004 Aug; 45 Suppl 1():S103-19. PubMed ID: 15261443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of malignant pleural mesothelioma and its sensitivity tests for anti-cancer drugs].
    Asakura S; Matsui T; Tatsumi A; Fujio A; Kitano M; Kobashi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jul; 26(7):695-9. PubMed ID: 3149385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.